Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels

Metabolism: Clinical and Experimental

Volumn 53, Issue 11, 2004, Pages 1436-1442

  Fredrikson, Gunilla Nordin ^a,b,c   Hedblad, Bo ^a,b   Nilsson, Jan Åke ^a,b   Alm, Ragnar ^a,b   Berglund, Göran ^a   Nilsson, Jan ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

^c University Hospital Malmö   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CAROTENE; CHOLESTEROL; FAT; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT INTAKE; FEMALE; HUMAN; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLISM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN INTAKE;

ALCOHOL DRINKING; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; DIETARY FATS; EDUCATIONAL STATUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOOD HABITS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; RISK FACTORS; SMOKING;

EID: 6944223243     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.06.010     Document Type: Article

References (48)

1. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 107:2003;363-369
2. Ridker P., Cushman M., Stampfer M., et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Eng J Med. 336:1997;973-979
3. Tracy R.P., Lemaitre R.N., Psaty B.M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 17:1997;1121-1127
4. Koenig W., Sund M., Frohlich M., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 99:1999;237-242
5. Ridker P.M., Hennekens C.H., Buring J.E., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342:2000;836-843
6. Ridker P.M., Stampfer M.J., Rifai N. Novel risk factors for systemic atherosclerosis A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 285:2001;2481-2485
7. Madsen T., Skou H.A., Hansen V.E., et al. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol. 88:2001;1139-1142
8. Sitzer M., Markus H.S., Mendall M.A., et al. C-reactive protein and carotid intimal medial thickness in a community population. J Cardiovasc Risk. 9:2002;97-103
9. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 340:1999;448-454
10. Torzewski M., Rist C., Mortensen R.F., et al. C-reactive protein in the arterial intima Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol. 20:2000;2094-2099
11. Zwaka T.P., Hombach V., Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages Implications for atherosclerosis. Circulation. 103:2001;1194-1197
12. Ridker P.M., Rifai N., Stampfer M.J., et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 101:2000;1767-1772
13. Ridker P.M., Rifai N., Pfeffer M., et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 101:2000;2149-2153
14. Yudkin J.S., Stehouwer C.D., Emeis J.J., et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 19:1999;972-978
15. Festa A., D'Agostino R. Jr, Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 102:2000;42-47
16. Pradhan A.D., Manson J.E., Rifai N., et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 286:2001;327-334
17. Freeman D.J., Norrie J., Caslake M.J., et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 51:2002;1596-1600
18. Ridker P.M., Buring J.E., Cook N.R., et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events An 8-year follow-up of 14 719 initially healthy American women. Circulation. 107:2003;391-397
19. Berglund G., Elmstahl S., Janzon L., et al. The Malmö Diet Cancer Study Design and feasibility. J Intern Med. 233:1993;43-51
20. Manjer J., Carlsson S., Elmstahl S., et al. The Malmo Diet and Cancer Study Representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 10:2001;489-499
21. Hedblad B., Wikstrand J., Janzon L., et al. Low dose metropolol CR/XL and fluvastatin slow progression of carotid intima-media thickness (IMT) Main results from the beta-blocker cholesterol asymptomatic plaque study (BCAPS). Circulation. 103:2001;1721-1726
22. Callmer E., Riboli E., Saracci R., et al. Dietary assessment methods evaluated in the Malmo food study. J Intern Med. 233:1993;53-57
23. Riboli E., Elmstahl S., Saracci R., et al. The Malmo Food Study Validity of two dietary assessment methods for measuring nutrient intake. Int J Epidemio. 26:(suppl 1):1997;S161-173
24. Elmstahl S., Riboli E., Lindgarde F., et al. The Malmo Food Study The relative validity of a modified diet history method and an extensive food frequency questionnaire for measuring food intake. Eur J Clin Nutr. 50:1996;143-151
25. Black A.E., Goldberg G.R., Jebb S.A., et al. Critical evaluation of energy intake data using fundamental principles of energy physiology: 2: Evaluating the results of published surveys. Eur J Clin Nutr. 45:1991;583-599
26. Black A. The sensitivity and specificity of the Goldberg cut-off for EI:BMR for identifying diet reports of poor validity. Eur J Clin Nutr. 54:2000;395-404
27. Taylor H.L., Jacobs D.R. Jr, Schucker B., et al. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 31:1978;741-755
28. Nordin Fredrikson G., Hedblad B., Berglund G., et al. Plasma oxidized LDL A predictor for acute myocardial infarction? J Intern Med. 253:2003;425-429
29. Ridker P.M. Novel risk factors and markers for coronary disease. Adv Intern Med. 45:2000;391-418
30. Lear S.A., Chen M.M., Birmingham C.L., et al. The relationship between simple anthropometric indices and C-reactive protein Ethnic and gender differences. Metabolism. 52:2003;1542-1546
31. Frohlich M., Imhof A., Berg G., et al. Association between C-reactive protein and features of the metabolic syndrome A population-based study. Diabetes Care. 23:2000;1835-1839
32. Hak A.E., Stehouwer C.D., Bots M.L., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 19:1999;1986-1991
33. Albert M.A., Glynn R.J., Ridker P.M. Effect of physical activity on serum C-reactive protein. Am J Cardiol. 93:2004;221-225
34. Wannamethee S.G., Lowe G.D., Whincup P.H., et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 105:2002;1785-1790
35. Dichtl W., Nilsson L., Goncalves I., et al. Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells. Circ Res. 84:1999;1085-1094
36. Dichtl W., Ares M.P., Stollenwerk M., et al. In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element. Thromb Haemost. 84:2000;706-711
37. Austin M.A., Krauss R.M. LDL density and atherosclerosis. JAMA. 273:1995;115
38. Shah P.K., Kaul S., Nilsson J., et al. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins an idea whose time for testing is coming, part I. Circulation. 104:2001;2376-2383
39. Schmidt A.M., Stern D. Atherosclerosis and diabetes the rage connection. Curr Atheroscler Rep. 2:2000;430-436
40. Ernst E., Saradeth T., Achhammer G. n-3 Fatty acids and acute-phase proteins. Eur J Clin Invest. 21:1991;77-82
41. De Caterina R., Cybulsky M.I., Clinton S.K., et al. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb. 14:1994;1829-1836
42. De Caterina R., Liao J.K., Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr. 71:2000;213S-223S
43. Endres S., Ghorbani R., Kelley V.E., et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 320:1989;265-271
44. Langlois M., Duprez D., Delanghe J., et al. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation. 103:2001;1863-1868
45. Devaraj S., Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med. 29:2000;790-792
46. Erlinger T.P., Guallar E., Miller E.R. 3rd, et al. Relationship between systemic markers of inflammation and serum beta-carotene levels. Arch Intern Med. 161:2001;1903-1908
47. Liu S., Manson J.E., Buring J.E., et al. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 75:2002;492-498
48. Wirfalt E., Hedblad B., Gullberg B., et al. Food patterns and components of the metabolic syndrome in men and women A cross-sectional study within the Malmo Diet and Cancer cohort. Am J Epidemiol. 154:2001